度普利尤单抗双重阻断IL-4与IL-13改善嗜酸性鼻窦炎小鼠的感觉神经性嗅觉功能障碍
研究采用卵清蛋白与曲霉蛋白酶鼻内给药12周诱导雄性BALB/c小鼠嗜酸性鼻窦炎症,并给予度普利尤单抗治疗。结果显示度普利尤单抗减少黏膜突起病变数量、降低嗜酸性粒细胞与中性粒细胞浸润、减轻嗅觉感觉神经元损伤,并下调嗅球中小胶质细胞活化与神经炎症相关mRNA表达。作者认为度普利尤单抗改善小鼠感觉神经性嗅觉功能障碍,可能解释慢性鼻窦炎伴鼻息肉患者嗅觉改善快于息肉缩小的现象。
要点
- 度普利尤单抗减少嗜酸性鼻窦炎小鼠黏膜突起病变数量及嗜酸性粒细胞、中性粒细胞浸润。
- 度普利尤单抗减轻嗅觉感觉神经元损伤并下调嗅球小胶质细胞活化与神经炎症相关mRNA表达。
- 作者认为度普利尤单抗改善小鼠感觉神经性嗅觉功能障碍,可能解释患者嗅觉改善快于息肉缩小。
核心结论
- 度普利尤单抗改善小鼠感觉神经性嗅觉功能障碍,可能解释慢性鼻窦炎伴鼻息肉患者嗅觉改善快于息肉缩小的现象。
研究设计与样本
- 雄性BALB/c小鼠经鼻内给予卵清蛋白与曲霉蛋白酶12周诱导嗜酸性鼻窦炎症,并给予度普利尤单抗治疗。
- 小鼠接受组织学评估、嗅觉行为学测试及嗅球神经炎症标志物基因表达谱分析。
主要发现
- 度普利尤单抗治疗使黏膜突起病变数量减少。
- 度普利尤单抗治疗使嗜酸性粒细胞与中性粒细胞浸润减少。
- 度普利尤单抗治疗使嗅觉感觉神经元损伤减少。
- 度普利尤单抗治疗使嗅球中小胶质细胞活化与神经炎症相关mRNA表达下调。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dupilumab, an antibody that binds IL-4Rα and inhibits IL-4 and IL-13 signals, has demonstrated efficacy in chronic rhinosinusitis with nasal polyps (CRSwNP) primarily characterized by type 2 inflammation. Current evidence suggests that the rate of improvement in olfactory dysfunction with dupilumab exceeds that of nasal polyp reduction, yet the underlying mechanism remains undisclosed. We hypothesize that dupilumab may initially ameliorate sensorineural olfactory dysfunction. METHODOLOGY: Male BALB/c mice were intranasally administered ovalbumin and Aspergillus protease for 12 weeks to induce eosinophilic sinonasal inflammation. Dupilumab treatment was also administered. The mice underwent histological assessment, olfactory behavioural test, and gene expression profiling to identify neuroinflammatory markers within the olfactory bulb. RESULTS: Dupilumab treatment resulted in a reduction in the number of mucosal protruding lesions, as well as decreased infiltration of eosinophils and neutrophils, along with a decrease in olfactory sensory neuron injury. Furthermore, there was a downregulation in the mRNA expression related to microglia activation and neuroinflammation in the olfactory bulb. CONCLUSIONS: Dupilumab improves the sensorineural pattern of olfactory dysfunction in mice, potentially explaining why olfaction improves more rapidly than polyp reduction in patients with CRSwNP.
引用
- Yeh CF, Lan MY, Lin CC, et al. Dual blockade of IL-4 and IL-13 with dupilumab ameliorates sensorineural olfactory dysfunction in mice with eosinophilic sinonasal inflammation. Rhinology. 2025. PMID: 39254928. doi:10.4193/Rhin24.114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。